Welcome to Comagine Health’s Safe Opioid Stewardship Program for Long-Term Care Settings. This page hosts essential resources that will help you build and enhance your opioid stewardship program as well as your substance use disorder supports and processes.
Along with helpful resources and toolkits, you will find our facility self-assessment that will help us understand your strengths, areas of improvement, and program specific needs.
Note: If you have landed on this page without our referral, we would like you to know that this program is still in a pilot phase, and we are working closely with our interdisciplinary advisory group as well as Dr. Melissa Cheng in order to create a well-rounded stewardship program.
General Mentorship Related to OUD Treatment
Medications for Opioid Use Disorder
- SAMHSA Treatment Improvement Protocol (TIP) 35: Enhancing Motivation for Change in Substance Use Disorder Treatment
- SAMHSA Treatment Improvement Protocol (TIP) 57: Trauma-Informed Care in Behavioral Health Services
- Texas Department of Family and Protective Services Trauma-Informed Care Training
- Oregon Health Authority: Ensuring Delivered Services are Trauma Informed
General Staffing Resources
Utah State Community Resources
- ASHP Guidelines on Preventing Diversion of Controlled Substances
- NP Safe Prescribing Of Controlled Substances While Avoiding Drug Diversion
Substance Abuse Confidentiality Regulations
- ASAM Quality Care Clinical Guidelines: National practice guidelines to provide information on evidence-based treatment of opioid use disorder and address all of the Food and Drug Administration (FDA)-approved medications available to treat addiction involving opioid use and opioid overdose.
- Health and Human Services (HHS) 42 CFR Part 2 Proposed Rule Fact Sheet: The 42 CFR Part 2 regulations serve to protect patient records created by federally funded programs for the treatment of SUD.
- ASAM eLearning Buprenorphine Waiver Course: Covers all forms of medications and treatments of opioid use disorder; provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved clinician by the Center for Substance Abuse Treatment (CSAT)/SAMHSA of DATA 2000 training.
- BupPractice: A collection of tools and resources to support primary care physicians in setting up and providing office-based treatment for opioid dependence and to aid those who manage and refer patients being maintained on buprenorphine
- Clinical Opiate Withdrawal Scale: A tool to assess opiate withdrawal.
- Disclosure of Substance Use Disorder Patient Records: SAMHSA decision guide on how to identify if your organization or practice needs to be compliant with HHS 42 CFR Part 2.
- Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence: Specific cautions regarding the use of methadone and buprenorphine.
- The Next Stage of Buprenorphine Care for Opioid Use Disorder: An article in the Annals of Internal Medicine, November 6, 2018.
- PCSS Providers Clinical Support System: A program funded by SAMHSA to train primary care clinicians in the evidence-based prevention and treatment of opioid use disorders and treatment of chronic pain.
- PCSS Clinical Tools: Provides clinical guidelines, forms, and useful links.
- PCSS Resources: Developed for health care professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.
- PCSS Medications for Addiction Treatment: Tailored mentoring options, online modules, webinars, small group discussions, clinical guidelines, coaching and waiver training.
- SAMHSA - Removal of DATA Waiver (X-Waiver) Requirement
- SAMHSA - Medication-Assisted Treatment (MAT): A comprehensive website with publications and related resources about medication-assisted treatment.
- SAMHSA - Treatment Improvement Protocol (TIP) 32: Clinical Drug Testing in Primary Care
- SAMHSA - Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder
- SAMHSA - Substance Abuse Confidentiality Regulations
- SAMHSA - Pharmacist Verification of Buprenorphine Providers: Tools and guidance for pharmacists to verify practitioner waivers to prescribe or dispense buprenorphine.
- FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks.
- Washington State Health Care Authority - Medication Treatment Guidelines for Substance Use Disorders (SUDs) - Transmucosal Buprenorphine: A resource on Medication Treatment Guidelines for SUDS - Buprenorphine Containing Products.
- Utah Support Advocates for Recovery Awareness (USARA): The USARA hotline is offering recovery services for people suffering from the effect of substance addiction. Contact them at (385) 210-0320.
- Utah 2-1-1: Utah 2-1-1 connects callers (at no cost) to critical community health and human services.
- CMS Opioid Misuse Strategy (2016)
- NIH National Pain Strategy
- Resources for Integrated Care: Promising Practices for Supporting Dually Eligible Older Adults with Complex Pain Needs
- CMS CMLN: Reducing Provider Burden and Burnout Through Substance Use Disorder Education
- Fact Sheet: Nevada's Oversight of Opioid Prescribing and Monitoring of Opioid Use
- AHRQ - Management of Opioid Use and Misuse in Older Adults: High-Leverage Changes for Improvement
- AHRQ - State of Opioid Use, Misuse and Opioid Use Disorder among Older Adults